Active	Status	Sponsor type	Region	Phase	Filter
19 Active 2 Inactive 21 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Ning
NCT05092841: A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A	Completed	3	176	RoW	PXT3003, (RS)-baclofen, naltrexone hydrochloride and D-sorbitol oral fixed dose combination, PXT3003 placebo, liquid oral solution	Tasly GeneNet Pharmaceuticals Co., Ltd	Charcot-Marie-Tooth Type 1A	03/24	03/24
TSL-CM-JSSPMFSL-Ⅲ, NCT06068465: A Study of the Safety and Efficacy of Pimavanserin in Patients with Parkinson's Disease Psychosis	Recruiting	3	248	RoW	pimavanserin tartrate, placebo	Tasly Pharmaceutical Group Co., Ltd	Parkinson's Disease Psychosis	06/25	01/26
C-BSEAL-002, NCT06276543: Bactiseal Catheter Safety Registry Study	Recruiting	N/A	200	RoW	antibiotic-impregnated catheter	Integra LifeSciences Corporation	Hydrocephalus	07/26	12/26
Chen, Wan-Jin
No trials found